Jazz Pharmaceuticals plc (J7Z) — Cash Flow Quality Index
Jazz Pharmaceuticals plc (J7Z) has a Cash Flow Quality Index of 1.39x as of March 2026. Operating cash flow of €408.20 Million exceeds net income of €293.10 Million, indicating high earnings quality where cash backs reported profits. Explore Jazz Pharmaceuticals plc cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Jazz Pharmaceuticals plc Cash Flow Quality Index (2013–2024)
Historical Cash Flow Quality Index for Jazz Pharmaceuticals plc across 10 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see Jazz Pharmaceuticals plc cash flow conversion.
Annual Cash Flow Quality Index for Jazz Pharmaceuticals plc (2013–2024)
Year-by-year earnings quality comparison for Jazz Pharmaceuticals plc.
| Year | Quality Index | Operating CF (EUR) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | 2.49x | €1.40 Billion | €560.12 Million | ▼ -5.3% |
| 2023 | 2.63x | €1.09 Billion | €414.83 Million | ▼ -30.2% |
| 2020 | 3.77x | €899.65 Million | €238.62 Million | ▲ +154.2% |
| 2019 | 1.48x | €776.40 Million | €523.37 Million | ▼ -17.0% |
| 2018 | 1.79x | €798.90 Million | €447.10 Million | ▲ +25.8% |
| 2017 | 1.42x | €693.09 Million | €487.85 Million | ▼ -4.8% |
| 2016 | 1.49x | €592.39 Million | €396.83 Million | ▼ -7.5% |
| 2015 | 1.61x | €531.94 Million | €329.54 Million | ▼ -76.9% |
| 2014 | 6.98x | €407.61 Million | €58.39 Million | ▲ +423.6% |
| 2013 | 1.33x | €288.43 Million | €216.31 Million | — |